Series Description: Join us for a dynamic three-part webinar series designed to empower home-based care providers across all service lines. This miniseries explores critical clinical practices that enhance safety, comfort, and quality of life for patients receiving care at home. Learn how to integrate naloxone protocols across service lines to prevent opioid-related harm and support emergency preparedness in the home setting. Discover strategies for purposeful, appropriate medication reduction across the continuum, with a deeper dive into how deprescribing fosters meaningful connection and dignity safety and comfort in hospice care. Explore best practices for managing complex pain at home, including when and how to rotate opioids to optimize relief and minimize side effects.
Whether you’re in hospice, home health, or personal care, this series offers actionable insights to elevate your clinical practice and deepen your impact.
Learning Outcomes: By the end of this miniseries, participants will be able to:
Identify appropriate indications for naloxone use in home-based care settings and implement standardized protocols to mitigate opioid-related adverse events and enhance emergency preparedness.
Evaluate polypharmacy risks and apply evidence-based deprescribing approaches across the care continuum, with emphasis on fostering patient-centered goals and relational depth in hospice care.
Assess complex pain scenarios and apply opioid rotation techniques to improve symptom control, reduce side effects, and tailor interventions to individual patient needs in home-based environments.
To view more details on each webinar descriptions, learning outcomes, and faculty, please select the topics below. Topics are subject to be fine-tuned closer to the webinar date. All webinars will be hosted 2-3 pm ET.
March 12, 2026 | Naloxone Use in Home Care
March 19, 2026 | Deprescribing and Relatedness
March 26, 2026 | Pain Management and Opioid Rotation
Faculty
The faculty (as indicated on each topic page) and the planners for these educational events have no relevant financial relationship(s) with ineligible companies to disclose.